| 常用名 | Navicixizumab | CAS号 | 1638338-43-8 |
|---|---|---|---|
| 价格 | 纯度 | 95.0% | |
| 备货期 | 10天 | 库存 | 现货 |
| 产品详情(用途,包装等)
用途: Navicixizumab (OMP-305B83) is a bispecific anti-VEGF and anti-DLL4 inhibitory antibody. Navicixizumab can combine with Paclitaxel (HY-B0015) for cancer research. Navicixizumab can be used in the research of ovarian, primary peritoneal, or fallopian tube cancer[1][2][3]. 物理化学性质: CAS号:1638338-43-8 常用中文名:Navicixizumab 常用英文名:Navicixizumab 分子式: 分子量: 密度:N/A 沸点:N/A 熔点:N/A 闪点:N/A |